Coronavirus disease 2019 vaccination acceptance and associated factors among residents of Dire Dawa Administration, Eastern Ethiopia: a community-based cross-sectional study.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

COVID-19 Vaccines*/administration & dosage ; COVID-19*/prevention & control ; COVID-19*/epidemiology ; SARS-CoV-2*/immunology ; Vaccination*/statistics & numerical data ; Vaccination*/psychology; Humans ; Ethiopia ; Male ; Cross-Sectional Studies ; Female ; Adult ; Middle Aged ; Young Adult ; Adolescent ; Surveys and Questionnaires ; Vaccination Hesitancy/statistics & numerical data ; Vaccination Hesitancy/psychology ; Patient Acceptance of Health Care/statistics & numerical data

Background: Corona virus disease 2019 (COVID-19) is an extremely contagious viral infection caused by the severe acute respiratory syndrome coronavirus 2. Understanding the willingness of the community to receive the COVID-19 vaccine will help in the development and implementation of effective COVID-19 vaccination promotion programs. Therefore, we aimed to assess the level of COVID-19 vaccine acceptance and associated factors among residents of Dire Dawa Administration, Eastern Ethiopia.
Methods: A community-based cross-sectional study was conducted among 840 residents in Dire Dawa Administration from May 18th to June 18th, 2021. Multistage cluster sampling followed by systematic random sampling was used to select respondents. A pretested interviewer-administered structured questionnaire was used to collect the data from respondents. Bivariable and multivariable logistic regression were used to identify predictors of COVID-19 vaccine acceptance. The odds ratio (OR), along with a 95% confidence interval (CI), was used to estimate the strength of the association.
Results: Out of 840 respondents recruited, the proportion of COVID-19 vaccine acceptance was found to be 54.4% (457/840); (95% CI: 51.0%, 57.7%) Being male [AOR = 1.85, 95% CI: (1.35, 2.54), P < 0.001], not having a current habit of substance use [AOR = 2.38, 95% CI: (1.73, 3.26), P < 0.001], having a monthly income of less than 51.31 USD [AOR = 0.19, 95% CI: (0.04, 0.88), P = 0.001]; and not having a prior history of vaccination experience [AOR = 0.40, 95% CI: (0.29, 0.54), P < 0.001] were significantly associated with COVID-19 vaccine acceptance.
Conclusion: This study reveals that the proportion of COVID-19 vaccine acceptance among residents of Dire Dawa Administration, Eastern Ethiopia, was 54.4%. Factors like being male and not having a current habit of substance use were positively associated, whereas having a monthly income of less than 51.31 USD and not having a prior history of vaccination experience were negatively associated with COVID-19 vaccine acceptance. Health information dissemination and economic empowerment are crucial to improving COVID-19 vaccine acceptance among the community. This study provides valuable data for policymakers to plan early vaccination programs and tackle the challenges identified in the study.
(© 2024. The Author(s).)

Ann Intern Med. 2020 Jul 21;173(2):157-160. (PMID: 32196071)
Vaccines (Basel). 2021 Feb 03;9(2):. (PMID: 33546165)
JAMA. 2020 May 26;323(20):2052-2059. (PMID: 32320003)
Glob Pediatr Health. 2021 Sep 30;8:2333794X211048738. (PMID: 34616860)
Vaccines (Basel). 2021 Mar 12;9(3):. (PMID: 33808958)
BMC Public Health. 2021 Apr 26;21(1):804. (PMID: 33902501)
BMJ. 2020 Aug 18;370:m3221. (PMID: 32816821)
Vaccines (Basel). 2020 Aug 27;8(3):. (PMID: 32867224)
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2276. (PMID: 33828622)
Vaccines (Basel). 2021 Feb 19;9(2):. (PMID: 33669659)
Infect Drug Resist. 2021 Jun 24;14:2361-2367. (PMID: 34194232)
Vaccine. 2021 Mar 19;39(12):1693-1700. (PMID: 33632563)
Am J Epidemiol. 1989 Jan;129(1):125-37. (PMID: 2910056)
Indian J Community Med. 2020 Oct-Dec;45(4):560-562. (PMID: 33623224)
BMC Public Health. 2021 Jun 12;21(1):1129. (PMID: 34118897)
Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100848. (PMID: 34395948)
Ann Transl Med. 2016 Mar;4(6):111. (PMID: 27127764)
Trop Med Health. 2021 May 13;49(1):37. (PMID: 33985592)
Clin Epidemiol Glob Health. 2022 Mar-Apr;14:101001. (PMID: 35284688)
PLoS One. 2022 Jan 13;17(1):e0261929. (PMID: 35025903)
Nicotine Tob Res. 2021 Aug 18;23(9):1623-1628. (PMID: 33751125)
Nat Med. 2021 Feb;27(2):225-228. (PMID: 33082575)
Psychol Sci. 2020 Jul;31(7):770-780. (PMID: 32603243)
Trop Med Health. 2021 Aug 9;49(1):63. (PMID: 34372943)
Infect Drug Resist. 2021 Jun 01;14:2015-2025. (PMID: 34103948)
Int J Gen Med. 2021 Jun 08;14:2385-2395. (PMID: 34135622)
Patient Prefer Adherence. 2021 Aug 17;15:1795-1805. (PMID: 34429591)
Vaccines (Basel). 2021 Mar 03;9(3):. (PMID: 33802285)
J Community Health. 2021 Dec;46(6):1090-1098. (PMID: 33956270)
Health Expect. 2022 Apr;25(2):506-512. (PMID: 33974721)
PLoS Curr. 2015 Feb 25;7:. (PMID: 25789200)
Vaccines (Basel). 2021 Feb 16;9(2):. (PMID: 33669441)
Med Princ Pract. 2021;30(3):262-271. (PMID: 33486492)
Lancet. 2020 Sep 26;396(10255):898-908. (PMID: 32919524)
Source Code Biol Med. 2008 Dec 16;3:17. (PMID: 19087314)
Soc Sci Med. 2021 Mar;272:113638. (PMID: 33414032)
SAGE Open Med. 2021 Aug 19;9:20503121211038454. (PMID: 34434555)
PLoS One. 2021 Sep 3;16(9):e0257109. (PMID: 34478470)
Front Public Health. 2021 Apr 21;9:626852. (PMID: 33968880)
Pragmat Obs Res. 2020 Oct 29;11:103-109. (PMID: 33154695)
Virusdisease. 2021 Jun;32(2):272-278. (PMID: 34222565)
Vaccine. 2020 Nov 17;38(49):7789-7798. (PMID: 33109389)
BMC Public Health. 2021 Oct 13;21(1):1851. (PMID: 34645399)

Keywords: Associated factors; Coronavirus disease 19 vaccine acceptance; Dire Dawa Administration; Residents

0 (COVID-19 Vaccines)

Date Created: 20240711 Date Completed: 20240712 Latest Revision: 20240714

20240714

PMC11238452

10.1186/s12879-024-09556-x

38992646